Original Query: ALL
Previous Study | Return to List | Next Study

Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients (AIR-CF5)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01375036
Recruitment Status : Completed
First Posted : June 17, 2011
Last Update Posted : January 11, 2017
Cystic Fibrosis Foundation Therapeutics
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2016
  Study Completion Date : December 2016